Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 10NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 7Breast 6Genitourinary 3Other hematologic neoplasm 2CNS 2Thoracic 1Sarcoma 1Plasma cell 1Gynecologic 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Neuroblastoma 1Central Nervous System Neoplasms 1

Interventions

Radiotherapy 63Temozolomide 59Magnetic Resonance Spectroscopy 46Carboplatin 40Cyclophosphamide 39Vincristine 35Specimen Handling 28Etoposide 26Cisplatin 26Radiation 22Chemotherapy, Adjuvant 22Filgrastim 20Bevacizumab 20Doxorubicin 18Peripheral Blood Stem Cell Transplantation 17Biopsy 17Vorinostat 16Surgical Procedures, Operative 14Melphalan 13Immunoglobulin G 13Disulfides 13Radiotherapy, Conformal 12Isotretinoin 12Erlotinib Hydrochloride 12X-Rays 11Nivolumab 11Irinotecan 11Carmustine 11aldesleukin 10Topotecan 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × pegfilgrastim × CNS × Clear all
NCT00075634 2013-09-30

Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Completed
21 enrolled
CNS

Neuroblastoma

NCT01172912 2013-08-12

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy

National Cancer Institute (NCI)

Phase 2 Unknown
47 enrolled
CNSGenitourinary

Testicular Germ Cell Tumor, Testicular Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡